Ciprofloxacin belongs to the class of medicines known as fluoroquinolone antibiotics. It works by killing the bacteria or preventing their growth. Dexamethasone is a steroid medicine that is used to relieve the redness, itching, and swelling caused by ear infections.
Ciprodex ear drops contain a combination of ciprofloxacin and dexamethasone. Ciprofloxacin is a quinolone antibiotic that treats infections caused by bacteria. Dexamethasone is a corticosteroid. It reduces the actions of chemicals in the body that cause inflammation.
Use Ciprodex for the full prescribed length of time. Your symptoms may improve before the infection is completely cleared. Skipping doses may also increase your risk of further infection that is resistant to antibiotics.
Ciprofloxacin and dexamethasone otic is used to treat outer ear infections in adults and children and acute (suddenly occurring) middle ear infections in children with ear tubes. Ciprofloxacin is in a class of medications called quinolone antibiotics. Dexamethasone is in a class of medications called corticosteroids. The combination of ciprofloxacin and dexamethasone works by killing the bacteria that cause infection and reducing swelling in the ear.
Ciprofloxacin and dexamethasone otic comes as a suspension (liquid) to place into the ear. It is usually used twice a day, in the morning and evening, for 7 days. Use ciprofloxacin and dexamethasone otic at around the same times every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Use ciprofloxacin and dexamethasone otic exactly as directed. Do not use more or less of it or use it more often than prescribed by your doctor.
Use ciprofloxacin and dexamethasone otic until you finish the prescription, even if you feel better. If you stop using ciprofloxacin and dexamethasone otic too soon or skip doses, your infection may not be completely treated and the bacteria may become resistant to antibiotics.
If someone swallows ciprofloxacin and dexamethasone otic, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.
Ciprofloxacin otic solution (Cetraxal) and ciprofloxacin otic suspension (Otiprio) are used to treat outer ear infections in adults and children. Ciprofloxacin otic suspension (Otiprio) is also used in children during ear tube placement surgery to prevent infection or ear drainage. Ciprofloxacin otic is in a class of medications called quinolone antibiotics. It works by killing the bacteria that cause infection.
Ciprofloxacin otic (Cetrexal) comes as a solution (liquid) to place into the ear. It is usually used twice a day for 7 days. Use ciprofloxacin otic solution at around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Use ciprofloxacin otic exactly as directed. Do not use more or less of it or use it more often than prescribed by your doctor.
Ciprofloxacin otic (Otiprio) also comes as a suspension (liquid) to be placed into the ear by a doctor or nurse in a doctor's office or other medical facility. Ciprofloxacin otic suspension (Otiprio) is usually given as a single dose.
You should begin to feel better during the first few days of treatment of out ear infections with ciprofloxacin otic. If your symptoms do not improve after one week or get worse, call your doctor. Also, call your doctor if you have ear pain, continuous ear discharge, or fever following use during ear tube surgery.
Ciprofloxacin otic (Cetrexal) ear drops come in single-use containers (small bottles to be used for one dose). Use the liquid from the container immediately after opening, and throw away the container when you are finished. Use ciprofloxacin otic ear drops until you finish the prescription, even if you feel better. If you stop using ciprofloxacin otic too soon or skip doses, your infection may not be completely treated and the bacteria may become resistant to antibiotics.
Tendon inflammation and/or rupture reported with systemic fluoroquinolones; exposure resulting from otic administration is substantially lower than systemic therapy; discontinue at first sign of tendon inflammation or pain
There are no available data on use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes; because of minimal systemic absorption of ciprofloxacin and dexamethasone following topical otic administration, product is expected to be of minimal risk for maternal and fetal toxicity when administered to pregnant women
Animal reproduction studies have not been conducted; oral administration of ciprofloxacin during organogenesis at doses up to 100 mg/kg to pregnant mice and rats, and up to 30 mg/kg to pregnant rabbits not reported to cause fetal malformations; these doses were at least 200 times the recommended otic human dose (ROHD in mice, rats, and rabbits, respectively, based on body surface area (BSA); with dexamethasone, malformations have been observed in animal studies after ocular and systemic administration
Published literature reports presence of ciprofloxacin in human milk after oral administration to lactating women; however, because of minimal systemic absorption of ciprofloxacin following topical otic administration, breastfeeding is not expected to result in exposure of infant to ciprofloxacin
Systemically administered corticosteroids appear in human milk; dexamethasone in breast milk could suppress growth, interfere with endogenous corticosteroid production, or cause other untoward effects; however, not known whether topical otic administration of drug could result in systemic absorption that is sufficient to produce detectable quantities of dexamethasone in human milk
Acute otitis media with tympanic membrane perforation in children should be treated with an oral antibiotic. (Strength of Recommendation [SOR]: A, based on meta-analysis of randomized controlled trials [RCTs]). Topical ciprofloxacin/dexamethasone (Ciprodex) is better than oral amoxicillin/clavulanic acid (Augmentin) for treating acute otitis media in children with tympanostomy tubes. (SOR: B, based on a small RCT). Topical quinolone antibiotics, with or without topical corticosteroids, are the best treatment for chronic suppurative otitis media. (SOR: A, based on systematic reviews of RCTs).
A meta-analysis of six RCTs of children six months to 12 years of age with acute otitis media examined the effectiveness of amoxicillin or amoxicillin/clavulanic acid versus placebo or delayed treatment in reducing pain, fever, or both at three to seven days. The authors concluded that antibiotics were more effective than placebo or delayed treatment in children with acute otitis media and otorrhea (relative risk [RR] = 0.52; 95% confidence interval [CI], 0.37 to 0.73; number needed to treat [NNT] = 3) versus children with acute otitis media without otorrhea (RR = 0.80; 95% CI, 0.70 to 0.92; NNT = 8).2
An industry-sponsored, single-blind RCT of 80 children six months to 12 years of age with tympanostomy tubes and acute otitis media compared ciprofloxacin/dexamethasone otic suspension with amoxicillin/clavulanic acid oral suspension. The children treated with ciprofloxacin/dexamethasone had a median time to cessation of otorrhea of four days compared with seven days for those treated with amoxicillin/clavulanic acid. Clinical cure, defined as cessation of otorrhea at 18 days, was 84.6 percent in the ciprofloxacin/dexamethasone group versus 58.5 percent in the amoxicillin/clavulanic acid group (RR = 0.69; 95% CI, 0.52 to 0.92; NNT = 4).3
A 2007 clinical evidence review of adults with chronic suppurative otitis media concluded that topical antibiotics, with or without topical corticosteroids, are likely to reduce persistent otorrhea.4 A 2005 Cochrane review included two short studies of variable quality (n = 197) that showed that topical quinolone antibiotics clear aural discharge better than no drug treatment (RR = 0.45; 95% CI, 0.34 to 0.59). The Cochrane review also included three studies (n = 263) that showed that topical quinolones were better than topical antiseptics, such as Burow's solution, povidone-iodine (Betadine), and boric acid, at clearing aural discharge (RR = 0.52; 95% CI, 0.41 to 0.67).5 Topical therapy with non-quinolone antibiotics appeared to work about as well, but the data were not as consistent. A 2006 Cochrane review of five generally short studies (n = 291) of variable quality found that topical quinolone antibiotics can clear aural discharge better at one to two weeks than systemic quinolone (RR = 3.18; 95% CI, 1.87 to 5.43) or nonquinolone antibiotics (RR = 3.21; 95% CI, 1.88 to 5.47).6
This medication is a combination product that contains two medications: ciprofloxacin and dexamethasone. Ciprofloxacin is an antibiotic that belongs to the family of medications known as fluoroquinolones. It is used for the treatment of infections caused by certain bacteria. Dexamethasone belongs to a family of medications known as corticosteroids. Corticosteroids reduce inflammation.
Each mL of otic suspension contains ciprofloxacin HCl (equivalent to ciprofloxacin base 3 mg) and dexamethasone 1 mg. Nonmedicinal ingredients: acetic acid, benzalkonium chloride 0.1 mg as preservative, boric acid, edetate disodium, hydroxyethyl cellulose, purified water, sodium acetate, sodium chloride, and tyloxapol. Sodium hydroxide and/or hydrochloric acid may be added for adjustment of pH.
Allergic reactions: Ciprofloxacin may cause a skin rash. If you notice skin rashes, skin blisters, itchy skin, hives, or other signs of an allergic reaction, stop using the medication and contact your doctor immediately. 59ce067264